Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Sale | -$140 K | -2.8 K | -0.61% | $50.16 | 460 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$160 K | -3.2 K | -0.7% | $50.09 | 457 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$210 K | -4.2 K | -0.92% | $50.03 | 453 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$310 K | -6.2 K | -1.37% | $50.06 | 446 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$456 K | -9.1 K | -2.04% | $50.14 | 437 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$476 K | -9.5 K | -2.17% | $50.15 | 428 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$492 K | -9.82 K | -2.3% | $50.07 | 418 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$586 K | -11.7 K | -2.8% | $50.10 | 406 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$777 K | -15.5 K | -3.82% | $50.12 | 391 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$1.51 M | -30.2 K | -7.73% | $50.02 | 360 K | Nov 11, 2021 | Direct | |
transaction | PFE | Common Stock | Sale | -$2.39 M | -47.8 K | -13.25% | $50.01 | 313 K | Nov 11, 2021 | Direct | |
holding | PFE | Common Stock | 2.55 K | Nov 11, 2021 | By Rule 16b-3 Plan | ||||||
holding | PFE | Common Stock | 1.62 K | Nov 11, 2021 | By Trustee under the Pfizer Share Ownership Plan |